JP2002535282A - 慢性心臓疾患を処置する方法 - Google Patents

慢性心臓疾患を処置する方法

Info

Publication number
JP2002535282A
JP2002535282A JP2000594481A JP2000594481A JP2002535282A JP 2002535282 A JP2002535282 A JP 2002535282A JP 2000594481 A JP2000594481 A JP 2000594481A JP 2000594481 A JP2000594481 A JP 2000594481A JP 2002535282 A JP2002535282 A JP 2002535282A
Authority
JP
Japan
Prior art keywords
heart disease
bpi
chronic heart
chronic
protein product
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000594481A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002535282A5 (https=
Inventor
ブレット ピー． ギロール，
パトリック ジェイ． スキャノン，
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Texas System
Original Assignee
University of Texas System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Texas System filed Critical University of Texas System
Publication of JP2002535282A publication Critical patent/JP2002535282A/ja
Publication of JP2002535282A5 publication Critical patent/JP2002535282A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A61K38/1751—Bactericidal/permeability-increasing protein [BPI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2000594481A 1999-01-22 2000-01-21 慢性心臓疾患を処置する方法 Pending JP2002535282A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11673699P 1999-01-22 1999-01-22
US60/116,736 1999-01-22
PCT/US2000/001515 WO2000043028A2 (en) 1999-01-22 2000-01-21 Method of treating chronic cardiac disease

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2007010878A Division JP2007126479A (ja) 1999-01-22 2007-01-19 慢性心臓疾患を処置する方法

Publications (2)

Publication Number Publication Date
JP2002535282A true JP2002535282A (ja) 2002-10-22
JP2002535282A5 JP2002535282A5 (https=) 2007-03-08

Family

ID=22368911

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2000594481A Pending JP2002535282A (ja) 1999-01-22 2000-01-21 慢性心臓疾患を処置する方法
JP2007010878A Withdrawn JP2007126479A (ja) 1999-01-22 2007-01-19 慢性心臓疾患を処置する方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2007010878A Withdrawn JP2007126479A (ja) 1999-01-22 2007-01-19 慢性心臓疾患を処置する方法

Country Status (11)

Country Link
US (3) US6509317B1 (https=)
EP (1) EP1143996B1 (https=)
JP (2) JP2002535282A (https=)
CN (1) CN1353614A (https=)
AT (1) ATE239492T1 (https=)
AU (1) AU778001B2 (https=)
CA (1) CA2359681A1 (https=)
DE (1) DE60002552T2 (https=)
MX (1) MXPA01007031A (https=)
NZ (1) NZ513087A (https=)
WO (1) WO2000043028A2 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004517865A (ja) 2000-12-01 2004-06-17 ゾーマ テクノロジー リミテッド Ｂｐｉタンパク質産物またはｂｐｉインヒビターを使用する、周皮細胞増殖の調節
US20110002893A1 (en) * 2008-11-03 2011-01-06 Ut-Battelle, Llc Diagnosis and treatment of congenital heart defects using nell1
US9974759B2 (en) * 2013-05-31 2018-05-22 Indiana University Research And Technology Corporation Beta 2 adrenoceptor antagonists for treating orthostatic hypotension
GB201319621D0 (en) 2013-11-06 2013-12-18 Norwegian University Of Science And Technology Antimicrobial agents and their use in therapy
GB201319620D0 (en) 2013-11-06 2013-12-18 Norwegian University Of Science And Technology Immunosuppressive agents and their use in therapy
WO2018002673A1 (en) 2016-07-01 2018-01-04 N4 Pharma Uk Limited Novel formulations of angiotensin ii receptor antagonists

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5578568A (en) * 1994-04-22 1996-11-26 Xoma Corporation Method of treating conditions associated with intestinal ischemia/reperfusion
WO1997042966A1 (en) * 1996-05-10 1997-11-20 Xoma Corporation Therapeutic uses of bpi protein products for human meningococcemia

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643875A (en) 1994-01-24 1997-07-01 Friedmann; Nadav Human therapeutic uses of bactericidal/permeability increasing (BPI) protein products
US5646114A (en) * 1994-07-11 1997-07-08 Xoma Corporation Anti-protozoan methods

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5578568A (en) * 1994-04-22 1996-11-26 Xoma Corporation Method of treating conditions associated with intestinal ischemia/reperfusion
WO1997042966A1 (en) * 1996-05-10 1997-11-20 Xoma Corporation Therapeutic uses of bpi protein products for human meningococcemia

Also Published As

Publication number Publication date
WO2000043028A9 (en) 2001-09-20
CA2359681A1 (en) 2000-07-27
NZ513087A (en) 2003-02-28
US20030216312A1 (en) 2003-11-20
DE60002552T2 (de) 2004-02-26
US20060171937A1 (en) 2006-08-03
ATE239492T1 (de) 2003-05-15
JP2007126479A (ja) 2007-05-24
EP1143996A4 (de) 2002-04-24
DE60002552D1 (de) 2003-06-12
AU778001B2 (en) 2004-11-11
AU2734100A (en) 2000-08-07
WO2000043028A2 (en) 2000-07-27
WO2000043028A3 (en) 2000-11-30
US6509317B1 (en) 2003-01-21
CN1353614A (zh) 2002-06-12
EP1143996A2 (en) 2001-10-17
US7045501B2 (en) 2006-05-16
MXPA01007031A (es) 2004-08-12
EP1143996B1 (en) 2003-05-07

Similar Documents

Publication Publication Date Title
US5888977A (en) Therapeutic uses of BPI protein products for human meningococcemia
US5912228A (en) Therapeutic compositions comprising bactericidal/permeability-increasing (BPI) protein products
US5756464A (en) Therapeutic uses of BPI protein products in humans with hemmorhage due to trauma
JPH09508357A (ja) 抗真菌方法及び材料
JP2007126479A (ja) 慢性心臓疾患を処置する方法
JP2002509527A (ja) 嚢胞性線維症におけるｂｐｉタンパク質産物の治療用途
US6153584A (en) Therapeutic uses of BPI protein products in BPI-deficient humans
WO2000018798A1 (en) Antifungal and antibacterial peptide
US6482796B2 (en) Therapeutic uses of N-terminal BPI protein products in ANCA-positive patients
US20060252688A1 (en) Therapeutic uses of BPI protein products in BPI-deficient humans
Scannon Therapeutic uses of BPI protein products for human meningococcemia
HK1019856B (en) Therapeutic uses of bpi protein products for human meningococcemia
AU2005201015A1 (en) Therapeutic uses of BPI protein products in BPI-deficient humans

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20070119

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070119

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100223

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100712